Pharma Journalist 8801 posts 0 comments

Global investment firm KKR announced that it has entered into a definitive agreement to purchase a controlling stake in J.B. Chemicals & Pharmaceuticals Ltd. (“J.B. Chemicals” or…
Read More...

Johnson & Johnson announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention…
Read More...

Bilthoven, The Netherlands based Intravacc, a worldwide leading translational research and development vaccine organization with an extensive track record in developing viral and…
Read More...

Pfizer Inc. and BioNTech SE  announced preliminary data from the most advanced of four investigational vaccine candidates from their BNT162 mRNA-based vaccine program, Project…
Read More...

BioInvent International AB announces that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer Inc. until…
Read More...

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient with triple negative breast cancer (TNBC) has been dosed in the ongoing phase 1 study…
Read More...

Aligos Therapeutics, Inc. (Aligos), a private biotechnology company focused on the development of targeted antiviral therapies directed against chronic hepatitis B (CHB), COVID-19 and…
Read More...

Prestige BioPharma Ltd. announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its first-in-class anti-PAUF monoclonal antibody, PBP1510,…
Read More...

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has approved Phesgo, a fixed-dose combination of Perjeta (pertuzumab) and Herceptin (trastuzumab) with hyaluronidase,…
Read More...